subject: Hpv Vaccine And Cervical Cancer [print this page] Warts are caused by a highly contagious virus known as the human papilloma virus, or HPV. As warts are highly contagious they have become very prevalent in the general population. They can occur virtually anywhere on the body. If afflicted with warts, it becomes necessary to eradicate the HPV infection to eliminate them.
Genital warts cures must be able to eliminate both the visible symptoms and the causative virus to be truly effective. Unfortunately, there are few successful medical options available. Surgically removing warts is the most common medical procedure. However, the patient is subject to a painful surgical intervention which results in skin damage/scarring along with the probability the warts will return.
Most pharmacology efforts now focus on developing a vaccine to inoculate the population in order to stop the HPV virus from infecting the system. This is ideal for the pharmaceutical companies as it would of course reap a monetary windfall of epic proportions for the drug companies, but not useful at all for those already affected with warts.
It would be desirable for an HPV vaccine to have the ability to prevent all cases of cervical cancer. It has therefore been necessary, at least for the first generation HPV vaccines, to focus on the HPV types found most frequently in cervical cancer. This consideration has led both companies to focus on HPV16 and HPV18, which account for about 70% of cases of cervical cancer.
When considering appropriate end points for determining vaccine efficacy, the most relevant end points recommended by an FDA vaccine advisory panel were a reduction in the incidence of vaccine type-specific persistent infections and of associated moderate- and high-grade cervical dysplasias and carcinomas in situ.
It is important to note that it would be unethical to use cervical cancer as a primary end point for vaccine efficacy trials, as cervical cancer screening can prevent the vast majority of cancer through the identification of precancers, which are then treated. Also, the interval between infection and the development of invasive cancer usually takes more than 10 years.
When fully vaccinated women who remained negative for infection throughout the vaccination period were analyzed against the comparable placebo cohort, the vaccine was 100% effective in preventing CIN2 associated with HPV16 or HPV18 and also in preventing external genital warts associated with HPV6 or HPV11.
Even when the efficacy was compared starting 1 month after the first immunization, protection for these end points was greater than 90%. Thus systemic immunization with a subunit HPV vaccine can achieve a high degree of protection in women against benign and premalignant diseases induced by this sexually transmitted local infection of the genital mucosa or skin.
The medical community has not had success to develop a treatment to successfully eradicate existing infections without causing extensive skin damage, trauma, or relapse. Importantly, China has now banned such vaccinations as they have found injecting a pathogen into your system does just that, it stays in your system, remaining latent in the joints, only to reappear in later years causing horrendous arthritis and or auto immune disorders.
Skin is comprised of the epidermis (outer layers), and the dermis which is referred to as the true skin (inner layers). The epidermis has 7 layers which protect and surrounds the true skin. Because the true skin is the reservoir of nourishment, it is the area where most dermatological problems begin and where the root of a wart resides.
This is why surgery to remove warts is so highly invasive, it must dig deep through all dermal layers, only to yield unsuccessful results when the warts reappear, despite best surgical efforts, the entire infection is almost never entirely cut out. So, this method to cure warts often fails as doctors are unable to remove the virus in its entirety, since it commonly lodges itself deep in the dermal layers of the skin.
As the antiviral properties of AntiWarts-Rx have the demonstrated ability to penetrate all layers of the skin and enter the blood stream via topical application, they have received considerable attention from the National Academy of Sciences and medical professionals on a global scale.
Viruses exhibit rapid rates of mutation which can make immunity difficult to sustain. Once a cell is infected it is difficult to selectively inhibit the virus without harming the host cell. As a result, much interest has focused on plants as strong allies in restoring immune strength and inhibiting the spread of viral diseases.
Some of the most impressive results consistently achieved with medicinal plants are in the elimination of warts. The antiviral activities of our antiwarts treatments are well documented and principally due to their direct effect to eradicate the HPV virus. To learn more, please go to http://www.naturespharma.org.
